B. Metzler seel. Sohn & Co. AG boosted its stake in shares of Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 13.7% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 77,865 shares of the company's stock after acquiring an additional 9,374 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in Keurig Dr Pepper were worth $2,665,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of KDP. Vanguard Group Inc. grew its position in shares of Keurig Dr Pepper by 21.3% during the first quarter. Vanguard Group Inc. now owns 145,012,806 shares of the company's stock valued at $4,962,338,000 after purchasing an additional 25,425,644 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Keurig Dr Pepper by 108.1% in the 1st quarter. JPMorgan Chase & Co. now owns 38,882,672 shares of the company's stock worth $1,330,565,000 after acquiring an additional 20,196,835 shares during the last quarter. Invesco Ltd. raised its holdings in shares of Keurig Dr Pepper by 1.7% during the 1st quarter. Invesco Ltd. now owns 21,973,128 shares of the company's stock worth $751,920,000 after acquiring an additional 367,518 shares in the last quarter. Northern Trust Corp increased its position in Keurig Dr Pepper by 0.8% in the first quarter. Northern Trust Corp now owns 13,712,677 shares of the company's stock worth $469,248,000 after purchasing an additional 114,044 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its stake in Keurig Dr Pepper by 3.6% during the first quarter. Dimensional Fund Advisors LP now owns 10,284,995 shares of the company's stock valued at $351,927,000 after purchasing an additional 358,350 shares in the last quarter. 93.99% of the stock is currently owned by institutional investors.
Insider Activity at Keurig Dr Pepper
In other Keurig Dr Pepper news, insider Mary Beth Denooyer sold 12,000 shares of the firm's stock in a transaction dated Thursday, July 17th. The stock was sold at an average price of $33.66, for a total value of $403,920.00. Following the completion of the sale, the insider owned 82,511 shares of the company's stock, valued at approximately $2,777,320.26. This trade represents a 12.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert James Gamgort sold 208,000 shares of the stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $32.90, for a total transaction of $6,843,200.00. Following the completion of the transaction, the director directly owned 2,292,169 shares of the company's stock, valued at $75,412,360.10. The trade was a 8.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 459,601 shares of company stock valued at $15,228,872 in the last ninety days. Corporate insiders own 1.00% of the company's stock.
Keurig Dr Pepper Stock Down 0.8%
Shares of NASDAQ KDP traded down $0.25 during midday trading on Tuesday, reaching $28.85. 19,007,894 shares of the company's stock traded hands, compared to its average volume of 12,660,778. The company has a market cap of $39.18 billion, a price-to-earnings ratio of 25.75, a P/E/G ratio of 1.59 and a beta of 0.47. The stock's 50 day simple moving average is $33.27 and its 200-day simple moving average is $33.59. The company has a quick ratio of 0.40, a current ratio of 0.64 and a debt-to-equity ratio of 0.56. Keurig Dr Pepper, Inc has a one year low of $28.60 and a one year high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The company reported $0.49 EPS for the quarter, hitting the consensus estimate of $0.49. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The firm had revenue of $4.16 billion during the quarter, compared to analyst estimates of $4.14 billion. During the same period in the previous year, the company posted $0.45 EPS. The business's revenue for the quarter was up 6.1% compared to the same quarter last year. On average, analysts predict that Keurig Dr Pepper, Inc will post 1.92 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
KDP has been the topic of several recent research reports. Hsbc Global Res cut shares of Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, August 26th. JPMorgan Chase & Co. dropped their target price on Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating for the company in a report on Thursday, July 17th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Keurig Dr Pepper from $40.00 to $38.00 and set a "buy" rating for the company in a research note on Tuesday, August 26th. Jefferies Financial Group set a $41.00 price target on shares of Keurig Dr Pepper in a research note on Monday, August 25th. Finally, Barclays boosted their price objective on Keurig Dr Pepper from $37.00 to $39.00 and gave the company an "overweight" rating in a report on Monday, July 28th. Eleven research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $38.38.
Check Out Our Latest Research Report on KDP
About Keurig Dr Pepper
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Articles

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report